Biopolym. Cell. 2013; 29(1):70-74.
http://dx.doi.org/10.7124/bc.000808
Bioorganic Chemistry
MI1 – derivative of maleimide inhibits cell cycle progression in tumor cells of epithelial origin
1Garmanchuk L. V., 1Denis E. O., 1Nikulina V. V., 1Dzhus O. I., 2Skachkova O. V., 1Ribalchenko V. K., 1Ostapchenko L. I.
  1. Educational and Scientific Center "Institute of Biology",
    Taras Shevchenko National University of Kyiv
    64/13, Volodymyrska Str., Kyiv, Ukraine, 01601
  2. National Cancer Institute
    33/43, Lomonosova Str., Kyiv, Ukraine, 03022

Abstract

Aim. MI1 is a promising maleimide derivative, which exhibits antiproliferative effect on different cells. The aim of present study was to investigate influence of MI1 on the cell cycle of cancer cells and its cytotoxity. Methods. The proliferative activity and viability of human cancer cell lines (colorectal adenocarcinoma – Colo-205; breast cancer – MCF-7; cervix cancer HeLa) obtained with MTT-test and cell counts were performed using a tripan blue dye. Distribution of cell cycle phases was obtained using flow cytometry method. Results. In the present study we demonstrate a detectable cytostatic effect of the maleimide derivative MI1 on the epithelial cell lines Colo-205, MCF-7 and HeLa. In the presence of MI1 the number of cells in the G2/M+S phases of the cell cycle dropped by 20–30 % (p < 0.05) relative to control. Conclusions. The results suggest that MI1 may be a perspective drug for antitumor therapy and perhaps deserves further study in detail.
Keywords: maleimide derivatives, cell cycle, cell culture
Full text: (PDF, in English)

References

[1] Blume-Jensen P., Hunter T. 2001 Oncogenic kinase signalling Nature 411, N 6835:355–365.
[2] Hanahan D., Weinberg R. A. 2011 Hallmarks of cancer: The next generation Cell 144, N 5:646–674.
[3] Novak K. K. 2004 Protein kinase inhibitors in cancer treatment: mixing and matching?: Highlights of the Keystone Symp. on Protein Kinases and Cancer (February 24–29, 2004; Lake Tahoe, California) Med. Gen. Med 6, N 2: 25.
[4] Perona R. 2006 Cell signalling: growth factors and tyrosine kinase receptors Clin. Transl. Oncol 8, N 2:77–82.
[5] Hers I., Tavare J. M., Denton R. M. 1999 The protein kinase C inhibitors bisindolylmaleimide I (GF 109203X) and IX (Ro318220) are potent inhibitors of glycogen kinase-3 activity FEBS Lett. 460, N 3:433–436.
[6] Pat. 22204 Ukraine. Compound of 1,4-disubstituted 5-amino-1,2-dihydropyrrole-3-one having anticancer activity / G. G. Dubinina, Yu. M. Volovenko U200601855; Appl. 21. 02.2006. Publ. 25.04.2007.
[7] Jaye M. C., Krawiec J. A., Campobasso N., Smallwood A., Qiu C., Lu Q., Kerrigan J. J., De Los Frailes Alvaro M., Laffitte B., Liu W. S., Marino J. P. Jr., Meyer C. R., Nichols J. A., Parks D. J., Perez P., Sarov-Blat L., Seepersaud S. D., Steplewski K. M., Thompson S. K., Wang P., Watson M. A., Webb C. L., Haigh D., Caravella J. A., Macphee C. H., Willson T. M., Collins J. L. 2005 Discovery of substituted maleimids as liver X receptor agonists and determination of a ligandbound crystal structure J. Med. Chem 48, N 17 P. 5419–5422.
[8] Yablonska S., Filinska O., Ostrovska G. 2008Antiproliferative properties and low hepatotoxicity of new cytostatic malemide derivate 33rd FEBS Congr. and 11th IUBMB Conf. on Biochemistry of cell regulation (June 28–July 3, 2008, Athens, Greese) Athens,:348.
[9] Lynchac O. V., Charchuk I. V., Karpezo N. O., Ostrovska G. V., Rybalchenko V. K. 2011 Morpho-functional state of the organs of gastro-intestinal tract under the maleimide derivate action during one month Modern Problems of Toxicology N 1–2 P. 52–55.
[10] Charchuk I. V., Karpezo N. O., Ostrovska G. V., Rybalchenko T. V., Lynchac O. V., Cyvinska S. M., Lenchuk O. P., Rybalchenko V. K. 2008 The morpho-functional chenges in the rat's testes under the influence of the new antineoplastic medcine derivate of maleimide. Modern Problems of Toxicology N 1:61–64.
[11] Lynchak O. Ostrovska G., Burlaka A2010. State of colon mucosal under the effects of new protein-tyrosine kinases inhibitor maleimide derivate Gut «GASTRO 2010–18th UEGW: Barcelona» 58 (Suppl II):A133.
[12] Lynchak O., Ostrovska G., Rybalchenko V. K. 2009 Effects of new maleimide derivate on the 1,2-dimethylhydrazine-induced colon carcinogenesis in rats Gut «GASTRO 2009 UEGW/ WCOG, London» 58 (Suppl. II):A334.
[13] Mosmann T. 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65, N 1–2:55–63.
[14] Nicoletti I. Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J. Immunol. Methods 139, N 2:271–279.